Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 208-634-1 | CAS number: 536-45-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
Combined Repeated Dose Toxicity Study with the Reproduction/Developmental Screening Test (according to OECD 422), rats:
NOAEL general toxicity = 500 mg/kg bw/day
NOAEL reproductive toxicity = 500 mg/kg bw/day
NOAEL Offspring = 500 mg/kg bw/day
Read-across from anisaldehyde (CAS 123-11-5)
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 500 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- The available information comprises an adequate and reliable study (Klimisch score 1) from a surrogate substance with similar structure and intrinsic properties. Read-across is justified based on (bio)transformation to common compound(s) (refer to endpoint discussion for further details). The selected study is thus sufficient to fulfil the standard information requirements set out in Annex VII, 8.5, in accordance with Annex XI, 1.5, of Regulation (EC) No 1907/2006.
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
Justification for read-across
There are no data available on toxicity to reproduction for sodium anisate or p-anisic acid (CAS 100-09-4). In order to fulfil the standard information requirements set out in Annex VIII - IX, 8.6, in accordance with Annex XI, 1.5, of Regulation (EC) No 1907/2006, read-across from structurally related substances was conducted. In accordance with Article 13 (1) of Regulation (EC) No 1907/2006, "information on intrinsic properties of substances may be generated by means other than tests, provided that the conditions set out in Annex XI are met.” In particular for human toxicity, information shall be generated whenever possible by means other than vertebrate animal tests, which includes the use of information from structurally related substances (grouping or read-across) “to avoid the need to test every substance for every endpoint”. For each specific endpoint the source substance(s) structurally closest to the target substance is/are chosen for read-across, with due regard to the requirements of adequacy and reliability of the available data. Structural similarities and similarities in properties and/or activities of the source and target substance are the basis of read-across. A detailed justification for the analogue read-across approach is provided in the technical dossier (see IUCLID Section 13).
Toxicity to reproduction: oral
A reliable oral Combined Repeated Dose Toxicity Study with the Reproduction/Developmental Toxicity Screening Test with anisaldehyde (CAS 123-11-5) is available and was performed according to OECD 422 (Hatano Research Institute, 2000) and in compliance with GLP. Groups of 13 male and 13 female Sprague-Dawley rats were exposed to the test substance at dose levels of 20, 100 and 500 mg/kg bw/day by oral gavage once daily for 7 days/week to males for at least 42 days (2 weeks premating, 2 weeks during mating, 2 weeks after the completion of mating period) and to females for at least 40 days (2 weeks premating, throughout mating periods up to 2 weeks, then throughout pregnancy and up to day 4 of lactation); mated females without parturition were dosed until the day corresponding to day 24 of gestation. Control animals (13 per sex and dose) received the concurrent vehicle, corn oil, only. Observations and examinations of the animals included clinical signs, body weight, food consumption, haematology, clinical chemistry, urinalysis, organ weights, gross necropsy, organ weights and histopathology. With respect to reproduction the following parameters were determined: estrous cycling, time to mating, duration of gestation, parturition difficulties, number of corpora lutea and implantation sites, number and sex of pups (stillborn and liveborn), postnatal mortality, presence of gross anomalies/external malformations, pup weights (on days 0 and 4 of lactation), necropsy of pups (scheduled necropsy and deceased animals).
General toxicity: No mortality was observed and except for transient salivation noted in most high dose animals, no clinical signs were noted. Relevant effects of local irritation were noted in the forestomach, leading to a NOAEL of 20 mg/kg bw/day for local effects. However, these effects are not relevant for humans. With respect to systemic toxicity, relevant effects were noted in the liver, but were considered adpative and not adverse in nature. Therefore, the NOAEL for systemic toxicity was set at 500 mg/kg bw/day.
Toxicity to reproduction: All animals mated and the copulation index and time to copulation was not significantly different in the testing groups compared to the control. There were no statistically significant differences in the number of corpora lutea, number of implantation sites, implantation index, gestation index and gestation length between the control group and the test substance-treated groups. No abnormalities were observed during parturition and lactation in any group. In high dose females a statistically significant decrease in the number of pregnant dams (6 vs 12 in the control) was noted. The respective fertility index was also reduced (46.2% vs 92.3% in the control). No test substance related effects were observed at 100 or 20 mg/kg bw/day. In the high dose group, when calculated for pregnant dams (n = 6), the number of pups born per litter was statistically significantly decreased (9.3 vs 14.0 in the control). When calculated for dams with live pups (n = 5), the number of live born pups (day 0 of lactation) per litter (10.6 vs 13.8 in the control) and the number of live pups (day 4 of lactation) per litter (10.2 vs. 14.8 in the control) was statistically significantly decreased. However, postnatal survival was not affected (viability index 96.0% vs 98.7% in the control). No external malformations were found in all pups born; and also there were no abnormalities in internal organs at autopsy on day 4 of lactation. In addition, no abnormalities were observed at autopsy of dead pups.
The NOAEL for reproductive toxicity was considered to be 100 mg/kg bw/day based on the reduced number of pregnant dams and reduced number of liveborn pups at 500 mg/kg bw/day.
The reduction in pregnancy rate and litter size noted at 500 mg/kg bw/day only, are considered to be secondary non-specific consequences of the rapid metabolism of anisaldehyde to p-anisic acid (Harrison, 2012; Lewis, 2016) which leads to an evident disproportionate increase and an elongation of high p-anisic acid concentrations in plasma. At this dose level, a saturation of the formation of the respective glycine conjugate as detoxifying mechanism has been observed. In the present reproductive toxicity study, dose levels have not been selected taking into account such toxicokinetic data. The disproportionate increase of endogenous p-anisic acid plasma levels based on overwhelmed elimination pathways is assumed to lead to acidosis which may be causative for the adverse effects observed. Effects of metabolic acidosis on sperm quality in animal species including the rat have been published (e.g., Callaghan, 2016; Toth, 1992).
Saturation processes in metabolism and / or excretion are evident at the tested high dose level following bolus administration of the test substance. This type of administration does not reflect the generally protracted exposure of humans that is not expected to lead saturation of metabolism and excretion. These differences in exposure need to be considered for the assessment of relevance of the observed effects to humans (Gelbke, 2008). Accordingly, the relevance of the observed reduction in fertility indices for humans is highly questionable and do not suffice to form a robust rationale for a classification of anisaldehyde as reproductive toxicant.
Accordingly, based on read across, also classification of the the target substance as reproductive toxicant is not warranted.
References
Callaghan, M, et al. 2016: Subacute ruminal acidosis reduces sperm quality in beef bulls. J. Animal Sci. 94(8): 3215-3228
Lewis, E.M. 2016: A 14-Day Percutaneous Study of p-Methoxybenzaldehyde in Rats, with an Oral (Gavage) Study Extension, Including an Evaluation of the Toxicokinetics of p-Methoxybenzaldehyde (study report), Testing laboratory: Charles River Laboratories, Inc. Horsham, PA, USA, Report no: 72608. Owner company: Research Institute for Fragrance Materials, Inc.,Woodcliff Lake, NJ, USA; Report date: Jun 24, 2016
Gelbke, P. 2008: Grundprinzipien für die Ableitung von Grenzwerten. In: Chemische Grenzwerte: Eine Standortbestimmung. Eds. Janich, P, Thieme, P.C., Psarros, N., Verlag Wiley-VCH, Chapter 6: pages 67-72
Harrison, R. 2012: p-Methoxybenzaldehyde: Compoarative In Vitro Metabolism using Mouse, Rat, Rabbit and Human Hepatocytes (study report), Test laboratory: Huntingdon Life Sciences. Huntingdon, UK, Report No CAQ0001. Owner company: Research Institute for Fragrance Materials, Inc.,Woodcliff Lake, NJ, USA; Report date: Oct 02, 2012
Toth, G.P. et al. 1992: Adverse male reproduction effects following subchronic exposure of rats to sodium dichloroacetate. Fundam. Appl. Toxciol. 19(1): 57-63
Mode of Action Analysis / Human Relevance Framework
There is no evidence for species specific effects of the substance. Therefore, the results of the studies are regarded as relevant for humans.
Justification for classification or non-classification
The data on toxicity to reproduction from the source substance, anisaldehyde (CAS 123 -11 -5), indicate adverse effects at 500 mg/kg bw/day (the highest dose tested). However, these effects are attributed to metabolic acidosis following high dose bolus administration of the analogue substance that leads to saturation of metabolic pathways and subsequent metabolic acidosis. As this treatment scenario is not representative of the generally protracted human exposure during which no such saturation of metabolism is expected, the observed effects do not warrant classification of the target substance with respect to reproductive toxicity and by analogy, no classification and labeling according to Regulation (EC) No. 1272/2008 is warranted for the target substance.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.